---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033843"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:36:40.400564+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Better Choice Q2 net income $2.7M (EPS $2.98) vs $3.0M loss YoY; rev down 19%

## Summary
- Net income of $2.7M in Q2 2024 vs $3.0M loss a year ago; EPS $2.98 vs $(4.27).
- Revenue $8.5M, down 19% YoY from $10.5M, but up 8% sequentially from Q1 2024.
- Gross margin improved 403 bps to 38%; operating loss improved 72% to $(0.7)M.
- Adjusted EBITDA improved 98% to less than $(0.1)M; includes $3.6M gain on debt extinguishment.
- Six-month 2024 net loss narrowed to $(0.2)M from $(6.4)M; revenue $16.4M vs $19.8M YoY.

## SEC filing metadata
- accession: 0001493152-24-033843
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315224033843/0001493152-24-033843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315224033843/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033843
- JSON: https://secwatch.observer/filing/0001493152-24-033843.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033843.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.